Intellectual property
SpectraCure has an active intellectual property strategy that includes continuous filing new patent applications to protect its innovative work and to constantly update and strengthen its patent portfolio concerning interstitial PDT and light dosimetry.

Advancing cancer treatment with IDOSE®
© SpectraCure AB, Magistratsvägen 10, SE 226 43 Lund, Sweden E-mail us